Provided by Tiger Fintech (Singapore) Pte. Ltd.

Terns Pharmaceuticals, Inc.

2.92
-0.2000-6.41%
Post-market: 2.920.00000.00%17:27 EDT
Volume:555.61K
Turnover:1.65M
Market Cap:254.91M
PE:-2.61
High:3.11
Open:3.10
Low:2.90
Close:3.12
Loading ...

Terns Pharmaceuticals Positioned for Success with Promising Oral Therapy TERN-601 Amid Novo Nordisk’s Setback

TIPRANKS
·
21 Dec 2024

Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Insider Monkey
·
17 Dec 2024

Terns Pharmaceuticals CEO & Director Acquires 423% More Stock

Simply Wall St.
·
11 Dec 2024

Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Terns Pharmaceuticals (TERN)

TIPRANKS
·
06 Dec 2024

Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Cartesian Therapeutics (RNAC) and Terns Pharmaceuticals (TERN)

TIPRANKS
·
06 Dec 2024

Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN), Trevi Therapeutics (TRVI) and Vigil Neuroscience Inc (VIGL)

TIPRANKS
·
05 Dec 2024

Buy Rating for Terns Pharmaceuticals Driven by Promising TERN-701 Efficacy and Safety

TIPRANKS
·
05 Dec 2024

Terns's stock soars as analysts cheer leukemia data - and predict more gains

Dow Jones
·
05 Dec 2024

Oppenheimer Adjusts Price Target on Terns Pharmaceuticals to $20 From $17, Keeps Outperform Rating

MT Newswires Live
·
04 Dec 2024

Terns Pharmaceuticals Price Target Maintained With a $7.50/Share by HC Wainwright & Co.

Dow Jones
·
04 Dec 2024

Terns Pharmaceuticals price target raised to $20 from $17 at Oppenheimer

TIPRANKS
·
04 Dec 2024

Terns Pharmaceuticals Shares up 5.4% on Early Data for Blood Cancer Drug

THOMSON REUTERS
·
03 Dec 2024

BUZZ-Terns Pharma rises on early data for blood cancer drug

Reuters
·
03 Dec 2024

Terns Pharmaceuticals Shares up About 6% Premarket After Co Announces Early Data for Experimental Blood Cancer Drug

THOMSON REUTERS
·
03 Dec 2024

Terns Pharmaceuticals Reports Promising Results in CML Trial

TIPRANKS
·
03 Dec 2024

Terns Pharmaceuticals announces early data from Phase 1 CARDINAL trial

TIPRANKS
·
03 Dec 2024